Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder in which brain cells, or neurons, slowly degenerate and die resulting in a gradual cognitive decline. AD does not have a known cure; this requires effective strategies to manage symptoms and slow its progression of this disease. This review paper delves into treatments, for Alzheimers disease (AD) such as cholinesterase inhibitors, NMDA antagonists and immunotherapies. The focus will be on exploring their effectiveness in early and mild to AD cases well as examining any potential side effects. This paper highlights the importance of treatment plans that take into account the nature of AD and emphasizes the significance of addressing both the underlying pathology and symptoms. After conducting an analysis on clinical trials, the conclusion is that cholinesterase inhibitor therapy stands out as the approach, for managing mild to moderate AD based on comprehensive clinical trial results and a comparative analysis.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
